Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis

被引:2
|
作者
Schytte, S
Hansen, M
Moller, S
Junker, P
Henriksen, JH
Hillingso, J
Teisner, B
机构
[1] Odense Univ Hosp, Dept Internal Med C, Odense, Denmark
[2] Hvidovre Univ Hosp, Dept Rheumatol, Connect Tissue Lab, Copenhagen, Denmark
[3] Univ Copenhagen, Hvidovre Hosp, Dept Clin Physiol, Copenhagen, Denmark
[4] Hvidovre Univ Hosp, Dept Gastroenterol, Copenhagen, Denmark
[5] Odense Univ, Dept Med Microbiol, Odense, Denmark
关键词
aminoterminal propeptide of type I procollagen; clearance; collagen; ELISA; liver cirrhosis; procollagen; size-chromatography;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The circulating level and splanchnic and renal extraction of serum type I procollagen aminoterminal propeptide (PINP) was studied in 20 patients with normal liver function and in 15 patients with alcoholic liver cirrhosis. In patients with alcoholic cirrhosis, the concentration of PINP in the femoral artery blood was significantly higher than in the group of patients with normal liver function (median 145 mu g/l, 95% CI 98-195 versus 57 mu g/l, 95% CI 42-92, p < 0.001). A significant decrease in the concentration of PINP between the femoral artery (median 57 mu g/l, 95% CI 42-92) and the hepatic vein (median 45 mu g/l, 95% CI 40-70, p < 0.001) was found in patients with normal liver function. rn this group we also observed a significantly higher concentration of PINP in femoral artery blood (median 60 mu g/l, 95% CI 45-87) as compared with that in renal vein (median 50 mu g/l, 95% CI 40-65, p < 0.001). In contrast, serum-PINP did not differ between arterial and hepatic or venous venous blood in patients with alcoholic cirrhosis. Size-chromatography revealed no significant change in the ratio of the high and low molecular forms of PINP following extraction in liver and kidney. It is concluded that circulating PINP is extracted in the normal liver and kidney, and that the serum concentration of PINP is significantly higher in patients with alcoholic cirrhosis than in patients with normal liver function. Both the hepatic and the renal clearance of PINP are seriously impaired/reduced in patients with alcoholic cirrhosis.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 36 条
  • [31] Effects of late evening snack including branched-chain amino acid on the function of hepatic parenchymal cells in patients with liver cirrhosis
    Koreeda, Chizu
    Seki, Toshihito
    Okazaki, Kazuichi
    Ha-Kawa, Sang Kil
    Sawada, Satoshi
    HEPATOLOGY RESEARCH, 2011, 41 (05) : 417 - 422
  • [32] Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial
    Kharaziha, Pedram
    Hellstrom, Per M.
    Noorinayer, Babak
    Farzaneh, Farivar
    Aghajani, Katayoun
    Jafari, Fereshteh
    Telkabadi, Mohammad
    Atashi, Amir
    Honardoost, Maryam
    Zali, Mohammad Reza
    Soleimani, Masoud
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (10) : 1199 - 1205
  • [33] Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases
    Gudowska-Sawczuk, Monika
    Wrona, Alicja
    Gruszewska, Ewa
    Cylwik, Bogdan
    Panasiuk, Anatol
    Flisiak, Robert
    Chrostek, Lech
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (1-2) : 125 - 130
  • [34] Prediction of janagliflozin pharmacokinetics in type 2 diabetes mellitus patients with liver cirrhosis or renal impairment using a physiologically based pharmacokinetic model
    Zhao, Hengli
    Wei, Yilin
    He, Kun
    Zhao, Xiaoyu
    Mu, Hongli
    Wen, Qing
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 179
  • [35] Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort
    Cathomas, R.
    Klingbiel, D.
    Geldart, T. R.
    Mead, G. M.
    Ellis, S.
    Wheater, M.
    Simmonds, P.
    Nagaraj, N.
    von Moos, R.
    Fehr, M.
    ANNALS OF ONCOLOGY, 2014, 25 (08) : 1591 - 1597
  • [36] MEASUREMENT OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I) IN NORMAL ADULTS, PATIENTS WITH LIVER-CIRRHOSIS AND ACROMEGALY - EXPERIENCE WITH A NEW COMPETITIVE ENZYME-IMMUNOASSAY
    KRATZSCH, J
    BLUM, WF
    SCHENKER, E
    KELLER, E
    JAHREIS, G
    HAUSTEIN, B
    VENTZ, M
    ROTZSCH, W
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1993, 101 (03): : 144 - 149